The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas Territories.
Matthew Dryden, Michael Corley, Natalie Wright, Aisha Andrewin, Ronald Georges, Shaun Ramroop, Sharra Greenaway, Nicholas Gent, Nadia Astwood, William Hardy, Helen Carter, Peter Moss, Rebecca Edwards, Alex Wonner, Ayo Oyinloye, Kevin Donovan
{"title":"The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas Territories.","authors":"Matthew Dryden, Michael Corley, Natalie Wright, Aisha Andrewin, Ronald Georges, Shaun Ramroop, Sharra Greenaway, Nicholas Gent, Nadia Astwood, William Hardy, Helen Carter, Peter Moss, Rebecca Edwards, Alex Wonner, Ayo Oyinloye, Kevin Donovan","doi":"10.1093/jac/dkae330","DOIUrl":null,"url":null,"abstract":"<p><p>The UK Overseas Territories (UKOTs) are small, often remote territories with historical and territorial links to the UK. They range from densely populated areas (Cayman, Bermuda, Gibraltar) to land with no permanent inhabitants (British Antarctic Territory, South Georgia). However, they are linked by ecosystem instability (the permacrisis) including antimicrobial resistance (AMR), climate change and biodiversity disruption. The Chief Medical Officers of the UKOTs met in June 2024 and were unanimous in their concerns about the threat of global AMR. They have issued this statement on their hopes and expectations for the United Nations' General Assembly High-Level Meeting, in September 2024. These may be summarized by the hope of achieving united and sustained global political will to reduce the threat of AMR by equitable access to treatments, prevention of AMR by sanitation and accurate diagnostics, and education in health care and the public.</p>","PeriodicalId":14969,"journal":{"name":"Journal of Antimicrobial Chemotherapy","volume":" ","pages":"2729-2730"},"PeriodicalIF":3.9000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531820/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antimicrobial Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jac/dkae330","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
The UK Overseas Territories (UKOTs) are small, often remote territories with historical and territorial links to the UK. They range from densely populated areas (Cayman, Bermuda, Gibraltar) to land with no permanent inhabitants (British Antarctic Territory, South Georgia). However, they are linked by ecosystem instability (the permacrisis) including antimicrobial resistance (AMR), climate change and biodiversity disruption. The Chief Medical Officers of the UKOTs met in June 2024 and were unanimous in their concerns about the threat of global AMR. They have issued this statement on their hopes and expectations for the United Nations' General Assembly High-Level Meeting, in September 2024. These may be summarized by the hope of achieving united and sustained global political will to reduce the threat of AMR by equitable access to treatments, prevention of AMR by sanitation and accurate diagnostics, and education in health care and the public.
英国海外领土(UKOTs)是与英国有历史和领土联系的小型领土,通常位于偏远地区。它们既有人口稠密的地区(开曼群岛、百慕大群岛、直布罗陀),也有没有常住居民的陆地(英属南极领地、南乔治亚岛)。然而,生态系统的不稳定性(permacrisis)将它们联系在一起,包括抗菌药耐药性 (AMR)、气候变化和生物多样性破坏。2024 年 6 月,英国海外领地的首席医疗官们召开会议,一致对全球 AMR 的威胁表示担忧。他们发表了这份声明,表达了对 2024 年 9 月联合国大会高级别会议的希望和期待。这些希望和期望可概括为:希望实现团结一致和持续的全球政治意愿,通过公平获得治疗、通过卫生设施和准确诊断预防 AMR 以及在医疗保健和公众中开展教育来减少 AMR 的威胁。
期刊介绍:
The Journal publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, and articles in veterinary medicine likely to have an impact on global health.